Market research
RAP.AU ResApp Health Limited
AU AUD Basic Materials
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.21
Community
Investor discussion
1 comment
Sign in to join the RAP.AU discussion.
5 years, 5 months ago
ResApp Health Limited is currently in a long term downtrend where the price is trading 39.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
ResApp Health Limited's total revenue rose by 128.2% to $59K since the same quarter in the previous year.
Its net income has increased by 18.1% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 102.3% to $-2M since the same quarter in the previous year.
Based on the above factors, ResApp Health Limited gets an overall score of 3/5.